Daily News Podcast

No meaningful decline in opioid use


 

Over the last decade, opioid use has not significantly declined, despite efforts to educate physicians about the risk of abuse. Also today, the Fitbit Flex is feasible and provides nuanced step-count data in patients with MS, even moderate alcohol use could worsen outcomes in nonalcoholic fatty liver disease, and a new study supports meningococcal B vaccine in children with rare diseases. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Bundle pay plan didn’t save money
MDedge Rheumatology
Brain damage, slight benefit seen in epinephrine cardiac arrest
MDedge Rheumatology
Is fibromyalgia one disorder – or two?
MDedge Rheumatology
Is fish oil’s heart benefit a fish tale?
MDedge Rheumatology
Blood pressure meds cut cognitive impairment risk
MDedge Rheumatology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Rheumatology
Free skin cancer screening highlights need
MDedge Rheumatology
Valsartan cancer risk is low
MDedge Rheumatology
Finally, new migraine drugs
MDedge Rheumatology
Changes to doctor payment for in-office drugs
MDedge Rheumatology